Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReSurge International is a global health non-profit organization dedicated to providing life-changing reconstructive surgical care and building local surgical capacity in low- and middle-income countries. Founded in 1969 as Interplast, it was the first organization to provide multidisciplinary reconstructive surgical care for free globally. The organization focuses on treating conditions such as cleft lips and palates, severe burns, and hand injuries while training the next generation of local reconstructive surgeons. By partnering with local medical professionals and hospitals, ReSurge ensures sustainable access to high-quality surgical care rather than relying solely on visiting missions. Their mission combines direct patient care with a robust educational model to transform healthcare infrastructure in underserved regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReSurge International.